HPR160 Analysis of the Time Spent by AIFA Committees for the Assessment of New Drugs: Impact of the Application of Managed Entry Agreements
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.1289
https://www.valueinhealthjournal.com/article/S1098-3015(22)03494-5/fulltext
Section Title :
Section Order :
10835
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03494-5&doi=10.1016/j.jval.2022.09.1289